Apogee Therapeutics, Inc. Current Assets
Apogee Therapeutics, Inc. (APGE) had Current Assets of $991.73 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-10
- 2026-06-30: Assets, Current $991.73M.
- 2026-03-31: Assets, Current $1.07B.
- 2025-12-31: Assets, Current $741.36M.
- 2025-09-30: Assets, Current $540.10M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $991.73M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $1.07B 10-Q · filed 2026-05-11 |
| 2025-12-31 | $741.36M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $540.10M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $516.12M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $521.53M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $529.71M 10-K · filed 2026-03-02 |
| 2024-09-30 | $534.48M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $681.85M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $820.61M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $398.41M 10-K · filed 2025-03-03 |
| 2023-09-30 | $426.42M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $130.67M 10-Q · filed 2023-08-28 |
| 2022-12-31 | $152.06M 10-K · filed 2024-03-05 |